Literature DB >> 30519998

Morphological changes in subregions of hippocampus and amygdala in major depressive disorder patients.

Zhijun Yao1, Yu Fu1, Jianfeng Wu2, Wenwen Zhang3, Yue Yu1, Zicheng Zhang1, Xia Wu4,5, Yalin Wang6, Bin Hu7.   

Abstract

Despite many neuroimaging studies in the past years, the neuroanatomical substrates of major depressive disorder (MDD) subcortical structures are still not well understood. Since hippocampus and amygdala are the two vital subcortical structures that most susceptible to MDD, finding the evidence of morphological changes in their subregions may bring some new insights for MDD research. Combining structural magnetic resonance imaging (MRI) with novel morphometry analysis methods, we recruited 25 MDD patients and 28 healthy controls (HC), and investigated their volume and morphological differences in hippocampus and amygdala. Relative to volumetric method, our methods detected more significant global morphological atrophies (p<0.05). More precisely, subiculum and cornu ammonis (CA) 1 subregions of bilateral hippocampus, lateral (LA) and basolateral ventromedial (BLVM) of left amygdala and LA, BLVM, central (CE), amygdalostriatal transition area (ASTR), anterior cortical (ACO) and anterior amygdaloid area (AAA) of right amygdala were demonstrated prone to atrophy. Correlation analyses between each subject's surface eigenvalues and Hamilton Depression Scale (HAMD) were then performed. Correlation results showed that atrophy areas in hippocampus and amygdala have slight tendencies of expanding into other subregions with the development of MDD. Finally, we performed group morphometric analysis and drew the atrophy and expansion areas between MDD-Medicated group (only 19 medicated subjects in MDD group were included) and HC group, found some preliminary evidence about subregional morphological resilience of hippocampus and amygdala. These findings revealed new pathophysiologic patterns in the subregions of hippocampus and amygdala, which can help with subsequent smaller-scale MDD research.

Entities:  

Keywords:  Amygdala; Hippocampus; Major depressive disorder; Morphometry; Subcortical structures

Mesh:

Year:  2020        PMID: 30519998      PMCID: PMC6551316          DOI: 10.1007/s11682-018-0003-1

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  111 in total

Review 1.  Neural circuits underlying the pathophysiology of mood disorders.

Authors:  Joseph L Price; Wayne C Drevets
Journal:  Trends Cogn Sci       Date:  2011-12-21       Impact factor: 20.229

2.  The global record of memory in hippocampal neuronal activity.

Authors:  E R Wood; P A Dudchenko; H Eichenbaum
Journal:  Nature       Date:  1999-02-18       Impact factor: 49.962

3.  Structural Plasticity of the Hippocampus and Amygdala Induced by Electroconvulsive Therapy in Major Depression.

Authors:  Shantanu H Joshi; Randall T Espinoza; Tara Pirnia; Jie Shi; Yalin Wang; Brandon Ayers; Amber Leaver; Roger P Woods; Katherine L Narr
Journal:  Biol Psychiatry       Date:  2015-03-05       Impact factor: 13.382

Review 4.  The economic burden of depression in the US: societal and patient perspectives.

Authors:  Paul E Greenberg; Howard G Birnbaum
Journal:  Expert Opin Pharmacother       Date:  2005-03       Impact factor: 3.889

Review 5.  Long-term synaptic depression.

Authors:  D J Linden; J A Connor
Journal:  Annu Rev Neurosci       Date:  1995       Impact factor: 12.449

6.  Enlargement of the amygdala in patients with a first episode of major depression.

Authors:  Thomas Frodl; Eva Meisenzahl; Thomas Zetzsche; Ronald Bottlender; Christine Born; Constanze Groll; Markus Jäger; Gerda Leinsinger; Klaus Hahn; Hans-Jürgen Möller
Journal:  Biol Psychiatry       Date:  2002-05-01       Impact factor: 13.382

Review 7.  The economic burden of depression and the cost-effectiveness of treatment.

Authors:  Philip S Wang; Gregory Simon; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

8.  Autobiographical memory in depression.

Authors:  J M Williams; J Scott
Journal:  Psychol Med       Date:  1988-08       Impact factor: 7.723

9.  Dynamics of the hippocampus during encoding and retrieval of face-name pairs.

Authors:  Michael M Zeineh; Stephen A Engel; Paul M Thompson; Susan Y Bookheimer
Journal:  Science       Date:  2003-01-24       Impact factor: 47.728

10.  The participation of cortical amygdala in innate, odour-driven behaviour.

Authors:  Cory M Root; Christine A Denny; René Hen; Richard Axel
Journal:  Nature       Date:  2014-11-05       Impact factor: 49.962

View more
  12 in total

1.  The impact of Alzheimer's disease susceptibility loci on lateral ventricular surface morphology in older adults.

Authors:  Shan Li; Na An; Nan Chen; Yin Wang; Lin Yang; Yalin Wang; Zhijun Yao; Bin Hu
Journal:  Brain Struct Funct       Date:  2022-01-14       Impact factor: 3.270

2.  Predicting Tau Accumulation in Cerebral Cortex with Multivariate MRI Morphometry Measurements, Sparse Coding, and Correntropy.

Authors:  Jianfeng Wu; Wenhui Zhu; Yi Su; Jie Gui; Natasha Lepore; Eric M Reiman; Richard J Caselli; Paul M Thompson; Kewei Chen; Yalin Wang
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2021-12-10

3.  Temporal Grading Index of Functional Network Topology Predicts Pain Perception of Patients With Chronic Back Pain.

Authors:  Zhonghua Li; Leilei Zhao; Jing Ji; Ben Ma; Zhiyong Zhao; Miao Wu; Weihao Zheng; Zhe Zhang
Journal:  Front Neurol       Date:  2022-06-10       Impact factor: 4.086

4.  Applying surface-based morphometry to study ventricular abnormalities of cognitively unimpaired subjects prior to clinically significant memory decline.

Authors:  Qunxi Dong; Wen Zhang; Cynthia M Stonnington; Jianfeng Wu; Boris A Gutman; Kewei Chen; Yi Su; Leslie C Baxter; Paul M Thompson; Eric M Reiman; Richard J Caselli; Yalin Wang
Journal:  Neuroimage Clin       Date:  2020-07-05       Impact factor: 4.881

5.  Applying surface-based hippocampal morphometry to study APOE-E4 allele dose effects in cognitively unimpaired subjects.

Authors:  Qunxi Dong; Wen Zhang; Jianfeng Wu; Bolun Li; Emily H Schron; Travis McMahon; Jie Shi; Boris A Gutman; Kewei Chen; Leslie C Baxter; Paul M Thompson; Eric M Reiman; Richard J Caselli; Yalin Wang
Journal:  Neuroimage Clin       Date:  2019-03-04       Impact factor: 4.881

6.  Chronic intermittent ethanol promotes ventral subiculum hyperexcitability via increases in extrinsic basolateral amygdala input and local network activity.

Authors:  Eva C Bach; Sarah E Ewin; Alexandra D Baldassaro; Hannah N Carlson; Jeffrey L Weiner
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.379

7.  Predicting Brain Amyloid Using Multivariate Morphometry Statistics, Sparse Coding, and Correntropy: Validation in 1,101 Individuals From the ADNI and OASIS Databases.

Authors:  Jianfeng Wu; Qunxi Dong; Jie Gui; Jie Zhang; Yi Su; Kewei Chen; Paul M Thompson; Richard J Caselli; Eric M Reiman; Jieping Ye; Yalin Wang
Journal:  Front Neurosci       Date:  2021-08-06       Impact factor: 4.677

Review 8.  Relationship between depression and olfactory sensory function: a review.

Authors:  Anna Athanassi; Romane Dorado Doncel; Kevin G Bath; Nathalie Mandairon
Journal:  Chem Senses       Date:  2021-01-01       Impact factor: 3.160

9.  Subcortical volumetric alterations as potential predictors of methylphenidate treatment response in youth with attention-deficit/hyperactivity disorder.

Authors:  Ji-Sahn Kim; Kyung Hwa Lee; Chan-Sop Hwang; Jae-Won Kim
Journal:  J Psychiatry Neurosci       Date:  2022-01-13       Impact factor: 6.186

10.  Total Triterpenes of Wolfiporia cocos (Schwein.) Ryvarden & Gilb Exerts Antidepressant-Like Effects in a Chronic Unpredictable Mild Stress Rat Model and Regulates the Levels of Neurotransmitters, HPA Axis and NLRP3 Pathway.

Authors:  Xiang Pan; Kezhuo Chen; Sijie Han; Xinyao Luo; Dandan Zhang; Hanrui Zhang; Lian Zhang; Xuxiang Zhou; Jing Li; Jingxian Fang; Shiqin Wang; Xiaochuan Ye
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.